Evidence map›Paper›PMID 23049870›Full record

ArticlePloS one2012

Antimicrobial peptide trichokonin VI-induced alterations in the morphological and nanomechanical properties of Bacillus subtilis.

Hai-Nan Su, Zhi-Hua Chen, Xiao-Yan Song, Xiu-Lan Chen, Mei Shi, Bai-Cheng Zhou, Xian Zhao, Yu-Zhong Zhang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Qualitative and Quantitative Changes toLangmuir : the ACS journal of surfaces and colloids · 2020
    Article
  6. Article
  7. Review
  8. Evidences for anti-mycobacterium activities of lipids and surfactants.World journal of microbiology & biotechnology · 2016
    Article
  9. The roles of cellular nanomechanics in cancer.Medicinal research reviews · 2015
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hai-Nan SuState Key Laboratory of Crystal Materials, Marine Biotechnology Research Center, Shandong University, Jinan, People's Republic of China.
Zhi-Hua Chen
Xiao-Yan Song
Xiu-Lan Chen
Mei Shi
Bai-Cheng Zhou
Xian Zhao
Yu-Zhong Zhang
Shandong University · CNState Key Laboratory of Microbial Technology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides are promising alternative antimicrobial agents compared to conventional antibiotics. Understanding the mode of action is important for their further application. We examined the interaction between trichokonin VI, a peptaibol isolated from Trichoderma pseudokoningii, and Bacillus subtilis, a representative Gram-positive bacterium. Trichokonin VI was effective against B. subtilis with a minimal inhibitory concentration of 25 µM. Trichokonin VI exhibited a concentration- and time-dependent effect against B. subtilis, which was studied using atomic force microscopy. The cell wall of B. subtilis collapsed and the roughness increased upon treatment with trichokonin VI. Nanoindentation experiments revealed a progressive decrease in the stiffness of the cells. Furthermore, the membrane permeabilization effect of trichokonin VI on B. subtilis was monitored, and the results suggest that the leakage of intracellular materials is a possible mechanism of action for trichokonin VI, which led to alterations in the morphological and nanomechanical properties of B. subtilis.

Indexed as

AlamethicinAnti-Infective AgentsBacillus subtilisDisease ProgressionMicrobial Sensitivity TestsMicroscopy, Atomic ForceModels, StatisticalNanotechnologyPeptidesPermeabilityStem CellsStress, MechanicalSurface PropertiesUltraviolet RaysAlamethicinAnti-Infective AgentsPeptidestrichokonin VI

Identifiers

PMID23049870
PMCPMC3458079
OpenAlexW2002832215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.